Showing results (131-140 of 139) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Journal of Viral Hepatitis|May 30, 2008
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver diseaseH Poustchi, A Mohamadkhani, S Bowden, et al.Australian and New Zealand Journal of Medicine|June 1, 1991
Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?R Lin, M N Schoeman, P I Craig, et al.International Journal of Obesity (2005)|March 10, 2011
Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie miceK S Bell-Anderson, L Aouad, H Williams, et al.Journal of Gastroenterology and Hepatology|October 30, 1998
Molecular epidemiology of hepatitis C in AustraliaS Kaba, U Dutta, K Byth, et al.The Medical Journal of Australia|September 3, 1990
Does hepatitis C virus play a role in "non-viral" chronic liver disease?C Liddle, E B Crewe, N R Swanson, et al.Hepatology (Baltimore, Md.)|February 3, 2000
Which patients with hepatitis C develop liver complications?M H Khan, G C Farrell, K Byth, et al.The Medical Journal of Australia|January 2, 1995
Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of responseR L Hope, M Weltman, J Dingley, et al.The Journal of Biological Chemistry|June 10, 1981
Cytochrome P-450 heme moiety. The specific target in drug-induced heme alkylationM A Correia, G C Farrell, S Olson, et al.British Journal of Cancer|April 5, 2012
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in miceB Shen, E S H Chu, G Zhao, et al.Pageof 14